Antibiotic Resistance: Opportunities and Challenges

Dear Colleagues,

Infectious diseases are a major cause of mortality. The advent of antibiotics markedly reduced infectious-disease-associated death and increased life expectancy, which underpin modern medicine. However, the number of infections is increasing globally, especially those which cannot be treated with the currently available antibiotics. Antibiotic resistance has become one of the greatest threats to human and animal health; it is predicted that antimicrobial-resistant infections will cause around 10 million deaths by 2050 and result in huge economic losses if no appropriate actions are taken. Therefore, it is critical that the latest achievements and challenges in antibiotic resistance are summarized.

This Special Issue aims to present recent advances in the area of antibiotic treatment and resistance. Original research manuscripts, short communications, reviews and case reports are all welcome. Topics of interest include, but are not limited to:

• The origin and evaluation of antibiotics resistance;
• Antibiotic resistance mechanisms in bacterial infection;
• Current antibiotic use;
• Current strategies in the management of antibiotics resistance;
• The exploration of new and potential antibacterial agents;
• The discovery of new antibiotics;
• The immune responses against bacterial infection;
• Host–microbiome–pathogen interaction.

Dr. Junyan Liu
Dr. Jing Guo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.